A UK-based drug services company, Ergomed Plc, is to be admitted to the Alternative Investment Market of the London Stock Exchange following a fundraising of £11 million. Shares in the company are expected to start trading on 15 July. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
